Impact of the Metabolic Syndrome on Macrovascular and Microvascular Outcomes in Type 2 Diabetes Mellitus | Zendy

C A Cull | Zendy; Christine C. Jensen | Zendy; Ravi Retnakaran | Zendy; Rury R. Holman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact of the Metabolic Syndrome on Macrovascular and Microvascular Outcomes in Type 2 Diabetes Mellitus

Author(s) -

C A Cull,

Christine C. Jensen,

Ravi Retnakaran,

Rury R. Holman

Publication year - 2007

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.107.733428

Subject(s) - medicine , diabetes mellitus , metabolic syndrome , type 2 diabetes mellitus , confidence interval , national cholesterol education program , type 2 diabetes , relative risk , prospective cohort study , macrovascular disease , disease , united kingdom prospective diabetes study , endocrinology

The metabolic syndrome (MetS) and type 2 diabetes mellitus are both associated with increased cardiovascular disease risk. We examined retrospectively the degree to which the presence of MetS in individuals with type 2 diabetes mellitus increased their risk of diabetic complications using United Kingdom Prospective Diabetes Study data.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research